Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 1001

Total Visits per Month

June 2025 July 2025 August 2025 September 2025 October 2025 November 2025 December 2025
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 29 24 28 26 19 21 13

File Downloads

Views
Kyriazopoulou.pdf 418

Top Country Views

Views

Top City Views

Views